BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 27, 2008
View Archived Issues
Indevus Closes $105M Note Deal Backed by Sanctura Royalties
Indevus Pharmaceuticals Inc. joined the ranks of biotechs leveraging royalty streams to access nondilutive financing. (BioWorld Today)
Read More
QLT Anticipates Excess of Cash Following Atrigel, Other Deals
Read More
Restarted Pharmalink Generates Promising Phase III Data in PPS
Read More
Novosom In-Licenses Antisense CD40 Inhibitors from Isis Pharma
Read More
Other News To Note
Read More
Clinic Roundup
Read More